IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-45383-z.html
   My bibliography  Save this article

AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation

Author

Listed:
  • Xin Wu

    (East China Normal University
    Shanxi Medical University)

  • Yuanhuan Yu

    (East China Normal University)

  • Meiyan Wang

    (East China Normal University
    Chongqing Institute of East China Normal University)

  • Di Dai

    (East China Normal University)

  • Jianli Yin

    (East China Normal University
    Chongqing Institute of East China Normal University)

  • Wenjing Liu

    (East China Normal University)

  • Deqiang Kong

    (East China Normal University)

  • Shasha Tang

    (Tongji University)

  • Meiyao Meng

    (East China Normal University)

  • Tian Gao

    (East China Normal University)

  • Yuanjin Zhang

    (East China Normal University)

  • Yang Zhou

    (East China Normal University
    East China Normal University)

  • Ningzi Guan

    (East China Normal University)

  • Shangang Zhao

    (University of Texas Health Science Center at San Antonio)

  • Haifeng Ye

    (East China Normal University
    Chongqing Institute of East China Normal University
    East China Normal University)

Abstract

Gene therapies provide treatment options for many diseases, but the safe and long-term control of therapeutic transgene expression remains a primary issue for clinical applications. Here, we develop a muscone-induced transgene system packaged into adeno-associated virus (AAV) vectors (AAVMUSE) based on a G protein-coupled murine olfactory receptor (MOR215-1) and a synthetic cAMP-responsive promoter (PCRE). Upon exposure to the trigger, muscone binds to MOR215-1 and activates the cAMP signaling pathway to initiate transgene expression. AAVMUSE enables remote, muscone dose- and exposure-time-dependent control of luciferase expression in the livers or lungs of mice for at least 20 weeks. Moreover, we apply this AAVMUSE to treat two chronic inflammatory diseases: nonalcoholic fatty liver disease (NAFLD) and allergic asthma, showing that inhalation of muscone—after only one injection of AAVMUSE—can achieve long-term controllable expression of therapeutic proteins (ΔhFGF21 or ΔmIL-4). Our odorant-molecule-controlled system can advance gene-based precision therapies for human diseases.

Suggested Citation

  • Xin Wu & Yuanhuan Yu & Meiyan Wang & Di Dai & Jianli Yin & Wenjing Liu & Deqiang Kong & Shasha Tang & Meiyao Meng & Tian Gao & Yuanjin Zhang & Yang Zhou & Ningzi Guan & Shangang Zhao & Haifeng Ye, 2024. "AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45383-z
    DOI: 10.1038/s41467-024-45383-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-45383-z
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-45383-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Luigi Naldini, 2015. "Gene therapy returns to centre stage," Nature, Nature, vol. 526(7573), pages 351-360, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jifeng Yu & Bangguo Zhou & Shen Zhang & Haohao Yin & Liping Sun & Yinying Pu & Boyang Zhou & Yikang Sun & Xiaolong Li & Yan Fang & Lifan Wang & Chongke Zhao & Dou Du & Yan Zhang & Huixiong Xu, 2022. "Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    2. Haobo Han & Jiakai Xing & Wenqi Chen & Jiaxin Jia & Quanshun Li, 2023. "Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    3. Aaldering, Lukas Jan & Leker, Jens & Song, Chie Hoon, 2019. "Uncovering the dynamics of market convergence through M&A," Technological Forecasting and Social Change, Elsevier, vol. 138(C), pages 95-114.
    4. Tinglong Dai & Sridhar Tayur, 2020. "OM Forum—Healthcare Operations Management: A Snapshot of Emerging Research," Manufacturing & Service Operations Management, INFORMS, vol. 22(5), pages 869-887, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45383-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.